Entero Healthcare Solutions Q1 FY27 results (Apr–Jun 2026) and concall

Consumer Services · Concall AI · Call held 10 Aug 2026

Company page: Entero Healthcare Solutions share price, financials & guidance record

Entero Healthcare Solutions reported a strong Q1 FY27, with significant revenue growth and margin expansion, achieving its full-year EBITDA margin guidance early. The company demonstrated improved capital efficiency with doubled ROCE and ROE. Strategic focus remains on organic growth, consolidation, and leveraging the MedTech segment, with no major new acquisitions in the quarter.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 38.2%, net profit up 73.3% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	1,301	1,359	1,339	1,404	1,571 +21%	1,707 +26%	1,910 +43%	1,940 +38%
Expenses	1,258	1,309	1,290	1,354	1,509	1,639	1,824	1,844
EBITDA	42	50	49	50	62 +48%	68 +36%	86 +76%	97 +94%
Margin	3%	4%	4%	4%	4%	4%	5%	5%
Other income	11	8	7	6	5	-4	4	3
Interest	11	10	10	11	12	14	17	21
Depreciation	7	8	8	9	10	10	15	12
Profit before tax	35	39	37	36	45 +29%	40 +3%	58 +57%	67 +86%
Tax rate	25%	25%	16%	17%	18%	16%	22%	22%
Net profit	26	29	31	30	37 +42%	34 +17%	45 +45%	52 +73%
EPS	5.43	5.85	5.90	6.39	7.26	6.35	6.44	8.77

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Consumer Services earnings calls